Last Close
Feb 06  •  01:15PM ET
60.16
Dollar change
+0.99
Percentage change
1.67
%
Index- P/E16.42 EPS (ttm)3.66 Insider Own0.00% Shs Outstand2.04B Perf Week16.59%
Market Cap121.35B Forward P/E11.28 EPS next Y5.33 Insider Trans- Shs Float2.02B Perf Month18.85%
Enterprise Value140.03B PEG1.93 EPS next Q1.19 Inst Own19.41% Short Float0.87% Perf Quarter28.85%
Income7.53B P/S2.81 EPS this Y3.63% Inst Trans-3.46% Short Ratio3.89 Perf Half Y60.09%
Sales43.11B P/B5.57 EPS next Y9.49% ROA9.61% Short Interest17.55M Perf YTD22.68%
Book/sh10.81 P/C26.49 EPS next 5Y5.84% ROE38.48% 52W High59.62 0.91% Perf Year59.58%
Cash/sh2.27 P/FCF15.40 EPS past 3/5Y-25.93% 0.08% ROIC18.01% 52W Low32.38 85.79% Perf 3Y69.51%
Dividend Est.1.89 (3.14%) EV/EBITDA9.75 Sales past 3/5Y6.03% -0.31% Gross Margin72.53% Volatility1.93% 1.68% Perf 5Y58.26%
Dividend TTM1.71 (2.84%) EV/Sales3.25 EPS Y/Y TTM132.14% Oper. Margin22.57% ATR (14)1.25 Perf 10Y45.17%
Dividend Ex-DateFeb 20, 2026 Quick Ratio0.54 Sales Y/Y TTM7.51% Profit Margin17.47% RSI (14)83.80 Recom2.57
Dividend Gr. 3/5Y8.97% -7.58% Current Ratio0.82 EPS Q/Q61.53% SMA2017.02% Beta0.45 Target Price51.10
Payout47.35% Debt/Eq1.08 Sales Q/Q10.17% SMA5020.73% Rel Volume1.23 Prev Close59.17
Employees68629 LT Debt/Eq0.90 EarningsFeb 04 BMO SMA20040.00% Avg Volume4.52M Price60.16
IPOMar 28, 1980 Option/ShortYes / Yes EPS/Sales Surpr.8.50% 3.23% Trades Volume3,329,199 Change1.67%
Date Action Analyst Rating Change Price Target Change
Jan-27-26Initiated Citigroup Neutral
Jan-06-26Downgrade Barclays Equal Weight → Underweight
Nov-25-25Upgrade BofA Securities Underperform → Neutral
Jun-03-25Downgrade Berenberg Buy → Hold
Apr-15-25Initiated Exane BNP Paribas Neutral $35.25
Feb-12-25Initiated Morgan Stanley Equal-Weight
Nov-15-24Downgrade Deutsche Bank Buy → Hold
Nov-12-24Downgrade Jefferies Buy → Hold $53 → $39.50
Oct-31-24Downgrade Guggenheim Buy → Neutral
Jul-08-24Downgrade UBS Buy → Neutral
Today 11:45AM
05:15AM
Feb-05-26 09:15AM
02:04AM
Feb-04-26 09:00PM
04:05PM Loading…
04:05PM
01:52PM
01:50PM
12:01PM
10:30AM
08:31AM
08:12AM
07:27AM
07:05AM
02:45AM
02:20AM Loading…
02:20AM
Feb-03-26 12:30PM
09:40AM
07:17AM
Feb-02-26 02:16PM
10:01AM
08:29AM
Feb-01-26 07:47AM
Jan-29-26 10:00AM
Jan-28-26 10:00AM
09:45AM
05:51AM
Jan-27-26 09:50AM
Jan-22-26 01:03AM
Jan-21-26 10:23AM
10:00AM Loading…
10:00AM
Jan-20-26 05:30PM
04:05PM
01:41PM
09:36AM
09:00AM
07:10AM
05:54AM
Jan-15-26 09:40AM
08:53AM
Jan-12-26 01:35PM
09:45AM
06:15AM
05:47AM
Jan-10-26 02:57PM
Jan-09-26 01:56PM
05:10AM
Jan-08-26 12:33PM
Jan-07-26 10:50AM
09:50AM
Jan-06-26 12:48PM
11:12AM
Jan-05-26 02:38PM
Dec-31-25 11:03AM
09:34AM
Dec-30-25 09:40AM
Dec-29-25 11:59PM
03:28AM
Dec-24-25 10:33AM
Dec-22-25 08:27AM
Dec-19-25 04:46PM
04:30PM
04:09PM
02:50PM
02:50PM
12:15PM
09:45AM
08:12AM
Dec-18-25 10:41AM
07:41AM
07:27AM
Dec-17-25 10:29AM
09:45AM
Dec-16-25 09:55PM
08:53AM
Dec-15-25 10:49AM
10:27AM
Dec-12-25 01:53PM
10:08AM
07:28AM
03:00AM
Dec-11-25 11:03AM
09:12AM
Dec-10-25 11:28AM
09:40AM
Dec-09-25 09:10AM
Dec-04-25 11:30AM
Dec-03-25 09:45AM
Dec-02-25 09:10AM
Dec-01-25 04:21PM
Nov-25-25 07:22PM
04:14AM
Nov-21-25 04:46PM
02:37PM
09:47AM
09:40AM
06:14AM
Nov-19-25 10:09PM
Nov-18-25 10:33AM
Nov-17-25 09:50AM
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GSK plc10% OwnerDec 11 '25Buy19.001,470,00027,930,00018,245,691Dec 15 04:32 PM